Literature DB >> 15332732

Seroepidemiological study of visceral leishmaniasis among humans and animal reservoirs in Bushehr province, Islamic Republic of Iran.

M Mohebali1, Y Hamzavi, G H Edrissian, A Forouzani.   

Abstract

Using direct agglutination tests, a survey of visceral leishmaniasis was carried out among children and adults from 13 villages and from nomadic tribes in Bushehr province during 1998-99. Of the 1496 plasma samples, the overall seropositive rate (titres > or = 1:3200) was 3.4%. Almost all cases (94.1%) were in children under 10 years old. Eighteen patients were diagnosed with kala azar; fever and splenomegaly were the predominant signs and symptoms. Parasitology and serology examinations of local animals identified dogs and jackals infected with Leishmania infantum. Suggestions for control of visceral leishmaniasis in this area are to eliminate stray dogs, identify cases among humans and suspected leashed dogs, and treat infected individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 15332732

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  13 in total

1.  A serological study of Leishmania infantum in dogs of Khorasan Razavi province, Iran.

Authors:  S Sabzevari; G R Razmi; A Naghibi; J Khoshnegah
Journal:  J Parasit Dis       Date:  2012-08-22

2.  Emergence of a new focus of visceral leishmaniasis due to Leishmania infantum in Golestan Province, north-eastern of Iran.

Authors:  Mahdi Fakhar; A Asadi Kia; Sh Gohardehi; M Sharif; M Mohebali; B Akhoundi; A Pagheh; Y Dadimoghadam; F Cheraghali
Journal:  J Parasit Dis       Date:  2013-05-21

3.  Leishmania major infection in a patient with visceral leishmaniasis: treatment with Amphotericin B.

Authors:  Mehdi Karamian; Mohammad Hossein Motazedian; Davood Mehrabani; Khodakaram Gholami
Journal:  Parasitol Res       Date:  2007-07-22       Impact factor: 2.289

4.  Molecular and parasitological study of cutaneous leishmaniasis in Bushehr province, southwest of the Islamic Republic of Iran: a cross-sectional study during 2009-2012.

Authors:  Mehdi Mohebali; Hossein Darabi; Homa Hajjaran; Mohammad Reza Shirzadi; Moradali Fouladvand; Soroor Charehdar; Mohammad Taghi Satvat; Foroogh Pakbaz; Katayoun Vahdat
Journal:  J Parasit Dis       Date:  2013-12-12

5.  Epidemiological aspects of visceral leishmaniasis in baft district, kerman province, southeast of iran.

Authors:  H Mahmoudvand; M Mohebali; I Sharifi; H Keshavarz; H Hajjaran; B Akhoundi; S Jahanbakhsh; M Zarean; A Javadi
Journal:  Iran J Parasitol       Date:  2011-03       Impact factor: 1.012

6.  Molecular and Seroepidemiological Survey of Visceral Leishmaniasis among Humans and Domestic Dogs in Mazandaran Province, North of Iran.

Authors:  M Fakhar; B Rahmati; S Gohardehi; M Mohebali; B Akhoundi; M Sharif; S Ali Mahdavi
Journal:  Iran J Parasitol       Date:  2011-12       Impact factor: 1.012

7.  Serological Survey and Associated Risk Factors of Visceral Leish-maniasis in Qom Province, Central Iran.

Authors:  Arash Rakhshanpour; Mehdi Mohebali; Behnaz Akhondi; Mohammad Taghi Rahimi; Mohammad Bagher Rokni
Journal:  Iran J Public Health       Date:  2014-01       Impact factor: 1.429

8.  Development and Assessment of Loop-Mediated Isothermal Amplification (LAMP) Assay for the Diagnosis of Human Visceral Leishmaniasis in Iran.

Authors:  Mehrdad Ghasemian; Mohammad Javad Gharavi; Lame Akhlaghi; Mehdi Mohebali; Ahmad Reza Meamar; Ehsan Aryan; Hormozd Oormazdi
Journal:  Iran J Parasitol       Date:  2014-03       Impact factor: 1.012

9.  Human visceral leishmaniasis in kermanshah province, Western iran, during 2011-2012.

Authors:  Y Hamzavi; B Hamzeh; M Mohebali; B Akhoundi; Kh Ajhang; N Khademi; K Ghadiri; H Bashiri; M Pajhouhan
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

10.  Presence of Leishmania and Brucella species in the golden jackal Canis aureus in Serbia.

Authors:  Duško Cirović; Dimosthenis Chochlakis; Snežana Tomanović; Ratko Sukara; Aleksandra Penezić; Yannis Tselentis; Anna Psaroulaki
Journal:  Biomed Res Int       Date:  2014-05-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.